STATE STREET CORP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$122,062
-2.1%
52,3870.0%0.00%
Q2 2023$124,681
-31.5%
52,387
-48.3%
0.00%
Q1 2023$181,982
-10.6%
101,247
-5.5%
0.00%
Q4 2022$203,516
+78.5%
107,114
+100.9%
0.00%
Q3 2022$114,000
-25.5%
53,317
-1.1%
0.00%
Q2 2022$153,000
-49.0%
53,927
-25.0%
0.00%
Q1 2022$300,000
-62.1%
71,900
-52.8%
0.00%
Q4 2021$791,000
+143.4%
152,372
+207.4%
0.00%
Q3 2021$325,000
+122.6%
49,566
+125.1%
0.00%
Q2 2021$146,000
+13.2%
22,019
-2.3%
0.00%
Q1 2021$129,000
-35.8%
22,5340.0%0.00%
Q4 2020$201,000
-28.7%
22,534
-7.1%
0.00%
Q3 2020$282,000
+55.8%
24,267
+115.4%
0.00%
Q2 2020$181,000
+154.9%
11,268
-4.9%
0.00%
Q1 2020$71,000
-57.7%
11,844
-6.8%
0.00%
Q4 2019$168,000
+5.0%
12,708
-1.5%
0.00%
Q3 2019$160,00012,9000.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders